These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 7940850)
1. Design and evaluation of a computer tool to aid early management of cyclosporine therapy after heart and heart-lung transplantation. Best NG; Tan KK; Trull AK; Spiegelhalter DJ; Hue KL; Caine N; Wallwork J Transplant Proc; 1994 Oct; 26(5):2716-7. PubMed ID: 7940850 [No Abstract] [Full Text] [Related]
2. Behavior of International Society for Heart and Lung Transplantation grade 2 cardiac rejection. Milano A; Livi U; Caforio AL; Bianco R; Casula R; Gambino A; Feltrin G; Legittimo A; Angelini A; Thiene G Transplant Proc; 1994 Oct; 26(5):2724. PubMed ID: 7940853 [No Abstract] [Full Text] [Related]
3. Optimal use of cyclosporine in cardiac transplantation. Miller LW Transplant Proc; 1994 Oct; 26(5):2700-3. PubMed ID: 7940846 [No Abstract] [Full Text] [Related]
4. Neoral conversion study: shift from Sandimmune classic formulation to Neoral in heart and lung transplant patients. Svendsen UG; Larsen KR; Allermand H; Thayssen P; Jensen SB; Pettersson G Transplant Proc; 1996 Aug; 28(4):2281. PubMed ID: 8769225 [No Abstract] [Full Text] [Related]
5. Follow-up after conversion to Neoral in stable heart transplant recipients. Pethig K; Geiger M; Korn A; Grote M; Christians U; Wahlers T Transplant Proc; 1996 Aug; 28(4):2282-4. PubMed ID: 8769226 [No Abstract] [Full Text] [Related]
6. Cytoimmunologic monitoring after heart and heart-lung transplantation. May RM; Cooper DK; Du Toit ED; Reichart B J Heart Transplant; 1990; 9(2):133-5. PubMed ID: 2319372 [TBL] [Abstract][Full Text] [Related]
8. Limited utility of early trough cyclosporine level monitoring to predict the rate of acute rejection in the first three months after cardiac transplantation. Jennison SH; Wesp AG; McBride LR; Miller LW Transplant Proc; 1994 Oct; 26(5):2732-5. PubMed ID: 7940857 [No Abstract] [Full Text] [Related]
9. Relative clinical impact of cyclosporine vs steroid induction therapy on renal function and allograft rejection in heart transplant recipients. Hanrahan JS; Ibrahim H; Tolman D; Kirchberg D; Salter D; Guerraty A; Mohanty PK Transplant Proc; 1996 Aug; 28(4):2107-8. PubMed ID: 8769168 [No Abstract] [Full Text] [Related]
10. Pulmonary rejection diagnosis after lung and heart-lung transplantation. Reichenspurner H; Dienemann H; Rihl M; Wagner F; Meiser BM; Kur F; Hammer C; Forst H; Kreuzer E; Reichart B Transplant Proc; 1993 Dec; 25(6):3299-300. PubMed ID: 8266550 [No Abstract] [Full Text] [Related]
12. Multi-organ transplantation: is there a protective effect against acute and chronic rejection? Pinderski LJ; Kirklin JK; McGiffin D; Brown R; Naftel DC; Young KR; Smith K; Bourge RC; Tallaj JA; Rayburn BK; Benza R; Zorn G; Leon K; Wille K; Deierhoi M; George JF J Heart Lung Transplant; 2005 Nov; 24(11):1828-33. PubMed ID: 16297789 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection. Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L Transplant Proc; 1993 Jun; 25(3 Suppl 2):57-8. PubMed ID: 8516945 [No Abstract] [Full Text] [Related]
14. Conversion from regular cyclosporine to microemulsion cyclosporine following heart transplantation. Heroux AL; LeBlanc MH; Beaudoin D; Simard S; Coulombe DA; Gleeton O; Lemieux MD; Doyle DP Transplant Proc; 1996 Dec; 28(6):3145-8. PubMed ID: 8962219 [No Abstract] [Full Text] [Related]
15. Additive immunosuppressive effect of hydroxycamptothecin and cyclosporine on rejection of heart transplantation in rats. Shi B; Cai M; Qian Y; Zhou W; Mo C; Wang Y Transplant Proc; 2007 Dec; 39(10):3429-31. PubMed ID: 18089398 [TBL] [Abstract][Full Text] [Related]
16. Induction therapy with cyclosporine and without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients. Jazzar A; Fagiuoli S; Sisson S; Zuhdi N; Cooper DK Transplant Proc; 1994 Oct; 26(5):2749. PubMed ID: 7940864 [No Abstract] [Full Text] [Related]
17. Xanthines: ideal immunosuppressants for combination with cyclosporine? Lin Y; Segers C; Mikhalsky D; Schönharting M; Waer M Transplant Proc; 1996 Dec; 28(6):3102. PubMed ID: 8962202 [No Abstract] [Full Text] [Related]
18. Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation. Meiser BM; Uberfuhr P; Fuchs A; Schulze C; Nollert G; Mair H; Martin S; Pfeiffer M; Reichenspurner H; Kreuzer E; Reichart B J Heart Lung Transplant; 1997 Aug; 16(8):795-800. PubMed ID: 9286771 [TBL] [Abstract][Full Text] [Related]
19. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients. Herzberg GZ; Rossi AF; Courtney M; Gelb BD J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760 [TBL] [Abstract][Full Text] [Related]
20. Relationship between pharmacokinetic parameters of cyclosporin and the incidence of acute rejection after heart transplantation. Aumente MD; Arizón JM; Segura J; López A; Albornoz R; Cárdenas M; Segura C Transplant Proc; 2005 Nov; 37(9):4014-7. PubMed ID: 16386613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]